After Michael Justiz’s younger brother was diagnosed with prostate cancer, Justiz realized he needed to be monitored for it. For years, he underwent blood tests to learn his risk for prostate cancer.

Elekta AB received U.S. FDA clearance for what it called a “groundbreaking upgrade” of its MR-Linac platform which can continuously calculate the movement of a tumor anywhere in the body. The company ...

Prostate cancer is the most commonly diagnosed cancer in the UK, with more than 63,000 new cases each year. Yet for many men, understanding their treatment options remains far from straightforward New ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The medical linear accelerator, commonly known as LINAC ...